drugset / Trial / NCT06678269
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
Phase 1
Recruiting
28 enrolled
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test different doses of abemaciclib to find the best dose in participants while receiving hormone therapy and radiation therapy.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2028-11-30
- Completion
- 2028-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abemaciclib | Small molecule | — | Oral |